The 2017 American Heart Association (AHA)/American College of Cardiology (ACC)/Heart Rhythm Society (HRS) Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (SCD) includes recommended use of the wearable cardioverter defibrillator (WCD) for a wide range of patients at risk for SCD, including post-MI, post-PCI, and NICM patients. The guideline contains additional information about preventing SCD for patients with ischemic and non-ischemic heart disease, as well as shared decision making for patients at risk of SCD.

Review guideline excerpts related to:

• Wearable cardioverter defibrillator
• Preventing SCD with HF medications
• Shared decision-making
• Primary prevention of SCD in patients with ischemic heart disease
• Secondary and Pprimary prevention of SCD in patients with NICM